One of GATK's strengths is its ability to perform tumor-normal pair analysis, which compares the genomic data from a patient's tumor and normal tissue to identify somatic mutations. This is crucial for distinguishing cancer-specific mutations from germline variants. Mutect2 is a tool within GATK specifically designed for this purpose, offering high sensitivity and specificity in detecting somatic mutations.
